Bortezomib improves adoptive carbonic anhydrase�IX‑specific chimeric antigen receptor‑modified NK92 cell therapy in mouse models of human renal cell carcinoma

Qing Zhang(South China University of Technology), Junnian Zheng(Xuzhou Medical College), Qiang Fu(Binzhou Medical University), Jiage Ding(Xuzhou Medical College), Yangna Miao(Xuzhou Medical College), Hongyan Liu(Queensland University of Technology), Zhenzhen Wang(Hebei Medical University), Hailong Li(Central South University), Jǐnjīng Xǔ(Nanjing Medical University), Huizhong Li(Jiangsu University), Mengmeng Lü(Xuzhou Medical College)
Oncology Reports
September 24, 2018
Cited by 29


Related Papers